Niac to discuss J&J vaccine and extending period between vaccine doses tomorrow

NIAC will have to weigh up the “very small risk” from the Johnson & Johnson vaccine versus the risk of Covid

The National Immunisation Advisory Committee (Niac) will meet tomorrow to consider the European Medicines Agency advice on the Johnson & Johnson vaccine and the issue of extending the period between vaccine doses, the Taoiseach has told the Dáil.

The European Medicines Agency (EMA) ruled yesterday that the benefits of the J&J vaccine outweigh the risk of any side effects.